Kaiser Permanente joins late-stage COVID-19 vaccine study

PRESS RELEASE Contact: Vincent Staupe vincent.p.staupe@kp.org 510-318-1557 Kerry Sinclair  ksinclair@webershandwick.com 310-710-0321 OAKLAND, Calif. — Kaiser Permanente began participating in a phase 3 clinical trial to test an investigational vaccine against SARS-CoV-2, the virus causing the current COVID-19 global pandemic. Kaiser Permanente … Read more…

Kaiser Foundation Health Plan and Hospitals Q1 2020 financial update

PRESS RELEASE Contact: Marc Brown marc.t.brown@kp.org 510-271-6328 Kaiser Permanente’s mission is to provide high-quality, affordable health care services and to improve the health of its members and communities it serves. As a nonprofit health care system, Kaiser Foundation Health Plan, … Read more…